LAUDISI, ANASTASIA
 Distribuzione geografica
Continente #
NA - Nord America 890
EU - Europa 61
AS - Asia 38
SA - Sud America 3
Totale 992
Nazione #
US - Stati Uniti d'America 889
SG - Singapore 16
IE - Irlanda 15
HK - Hong Kong 10
CN - Cina 9
DE - Germania 7
IT - Italia 7
RU - Federazione Russa 6
UA - Ucraina 6
SE - Svezia 5
FR - Francia 4
PL - Polonia 4
GB - Regno Unito 3
FI - Finlandia 2
AR - Argentina 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
ID - Indonesia 1
KG - Kirghizistan 1
KR - Corea 1
NL - Olanda 1
RO - Romania 1
Totale 992
Città #
Wilmington 294
Houston 272
Woodbridge 136
Fairfield 44
Seattle 19
Chandler 18
Cambridge 17
Ashburn 15
Dublin 15
Singapore 14
Ann Arbor 12
Hong Kong 10
Medford 10
Jacksonville 6
Lawrence 5
Dearborn 4
Kraków 4
Santa Clara 4
Beijing 3
Del Norte 2
Ningbo 2
Rome 2
San Diego 2
Amsterdam 1
Council Bluffs 1
Hefei 1
Helsinki 1
Jakarta 1
Jinan 1
London 1
Milan 1
Moscow 1
Mülheim 1
Nuremberg 1
Phoenix 1
Prescot 1
Redwood City 1
Salt Lake City 1
Stella Cilento 1
Toronto 1
Trento 1
Wenzhou 1
Wuhan 1
Yellow Springs 1
Totale 931
Nome #
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 397
Prognostic significance of neutrophil-to-lymphocyte ratio in the framework of the 8th TNM edition for breast cancer 262
Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction 148
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: An Italian multicenter real life study 147
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study 66
Totale 1.020
Categoria #
all - tutte 2.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020194 0 0 0 0 0 0 25 22 46 39 32 30
2020/2021297 33 28 41 40 30 38 40 29 4 7 3 4
2021/202250 3 8 1 2 1 5 3 2 5 6 2 12
2022/202351 5 5 3 3 4 14 8 1 3 0 2 3
2023/202418 3 1 1 1 1 1 1 0 0 1 4 4
2024/202539 3 13 5 5 1 10 2 0 0 0 0 0
Totale 1.020